⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10157463 | 0.77 | — | — | |
| SCHEMBL1387720 | 0.76 | — | — | |
| SCHEMBL12181542 | 0.75 | — | — | |
| SCHEMBL20471489 | 0.72 | DHODH (0.33) | — | |
| SCHEMBL14822489 | 0.72 | HCAR2 (0.43) | — | |
| SCHEMBL4039141 | 0.65 | — | — | |
| SCHEMBL31234041 | 0.65 | — | — | |
| SCHEMBL772909 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL9346585 | 0.63 | KDM4E (0.53) | — | |
| SCHEMBL20919925 | 0.60 | DYRK1A (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025227032-A1 | METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES | REMIX THERAPEUTICS INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20080125418-A1 | Benzimidazole derivatives and their use as kdr kinase protein inhibitors | AVENTIS PHARMA S.A. (FR) | 2008-05-29 | — | — | US | disclosed |